Vaginal cancer risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
Line 7: Line 7:


==Risk factors==
==Risk factors==
Clinical data has suggested that the development of vaginal cancer is related to several factors.  
Clinical data has suggested that the development of [[vaginal cancer]] is related to several factors.  


*'''[[Vaginal adenosis]]: '''
*'''[[Vaginal adenosis]]: '''
:* Clinical research suggest that having adenosis increases the risk of developing clear cell carcinoma. Although it is very small, many doctors feel that any woman with adenosis should have very careful screening and follow-up<ref name="pmid2680951">{{cite journal |vauthors=Vessey MP |title=Epidemiological studies of the effects of diethylstilboestrol |journal=IARC Sci. Publ. |volume= |issue=96 |pages=335–48 |date=1989 |pmid=2680951 |doi= |url=}}</ref>.   
:* Clinical research suggest that having [[adenosis]] increases the risk of developing [[clear cell carcinoma]]. Although it is very small, many doctors feel that any woman with [[adenosis]] should have very careful screening and follow-up<ref name="pmid2680951">{{cite journal |vauthors=Vessey MP |title=Epidemiological studies of the effects of diethylstilboestrol |journal=IARC Sci. Publ. |volume= |issue=96 |pages=335–48 |date=1989 |pmid=2680951 |doi= |url=}}</ref>.   
*'''[[Cervical cancer]]: '''
*'''[[Cervical cancer]]: '''


:* Surveies show having cervical cancer increases the risk of vaginal squamous cell cancer. This is most likely because cervical and vaginal cancers have similar risk factors<ref name="pmid30539058">{{cite journal |vauthors=Jain G, Sabeena S, Vasudeva A, Mundkur A, Srinivas SP, Arunkumar G, Kumar P |title=A report of human papilloma virus-16 associated vaginal carcinoma after thirty-two years of successful radiation therapy for cervical cancer |journal=Virusdisease |volume=29 |issue=4 |pages=537–539 |date=December 2018 |pmid=30539058 |doi=10.1007/s13337-018-0479-8 |url=}}</ref>.
:* Surveys show having [[cervical cancer]] increases the risk of [[vaginal]] [[squamous cell cancer]]. This is most likely because [[cervical]] and [[vaginal cancers]] have similar risk factors<ref name="pmid30539058">{{cite journal |vauthors=Jain G, Sabeena S, Vasudeva A, Mundkur A, Srinivas SP, Arunkumar G, Kumar P |title=A report of human papilloma virus-16 associated vaginal carcinoma after thirty-two years of successful radiation therapy for cervical cancer |journal=Virusdisease |volume=29 |issue=4 |pages=537–539 |date=December 2018 |pmid=30539058 |doi=10.1007/s13337-018-0479-8 |url=}}</ref>.
*'''[[Diethylstilbestrol]] (DES): '''
*'''[[Diethylstilbestrol]] (DES): '''


:* Clinical data show women whose mothers took Diethylstilbestrol (DES) develop clear-cell [[adenocarcinoma]] of the vagina more often than would normally be expected. These women are called "DES daughters"<ref name="pmid28689666">{{cite journal |vauthors=Huo D, Anderson D, Palmer JR, Herbst AL |title=Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up |journal=Gynecol. Oncol. |volume=146 |issue=3 |pages=566–571 |date=September 2017 |pmid=28689666 |doi=10.1016/j.ygyno.2017.06.028 |url=}}</ref>.
:* Clinical data show women whose mothers took [[Diethylstilbestrol]] ([[DES]]) develop [[clear-cell]] [[adenocarcinoma]] of the [[vagina]] more often than would normally be expected. These women are called "DES daughters"<ref name="pmid28689666">{{cite journal |vauthors=Huo D, Anderson D, Palmer JR, Herbst AL |title=Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up |journal=Gynecol. Oncol. |volume=146 |issue=3 |pages=566–571 |date=September 2017 |pmid=28689666 |doi=10.1016/j.ygyno.2017.06.028 |url=}}</ref>.
*'''[[Human papillomavirus]] (HPV) infection: '''
*'''[[Human papillomavirus]] (HPV) infection: '''


:* Certain types of HPV (type 16 and 18) have been strongly associated with vaginal cancers<ref name="pmid29962490">{{cite journal |vauthors=Pham TTT, Bi X, Hoang HTT, Ishizaki A, Nguyen MTP, Nguyen CH, Nguyen HP, Pham TV, Ichimura H |title=Human Papillomavirus Genotypes and HPV16 E6/E7 Variants among Patients with Genital Cancers in Vietnam |journal=Jpn. J. Infect. Dis. |volume=71 |issue=6 |pages=419–426 |date=November 2018 |pmid=29962490 |doi=10.7883/yoken.JJID.2018.206 |url=}}</ref>.
:* Certain types of [[HPV]] (type 16 and 18) have been strongly associated with [[vaginal cancers]]<ref name="pmid29962490">{{cite journal |vauthors=Pham TTT, Bi X, Hoang HTT, Ishizaki A, Nguyen MTP, Nguyen CH, Nguyen HP, Pham TV, Ichimura H |title=Human Papillomavirus Genotypes and HPV16 E6/E7 Variants among Patients with Genital Cancers in Vietnam |journal=Jpn. J. Infect. Dis. |volume=71 |issue=6 |pages=419–426 |date=November 2018 |pmid=29962490 |doi=10.7883/yoken.JJID.2018.206 |url=}}</ref>.
*'''[[HIV]] infection: '''
*'''[[HIV]] infection: '''


:* Clinical studies show human immunodeficiency virus (HIV) also increases the risk of vaginal cancer<ref name="pmid25505037">{{cite journal |vauthors=Davies O, Rajamanoharan S, Balachandran T |title=Cervical screening in HIV-positive women in the East of England: recent CD4 as the predictive risk factor |journal=Int J STD AIDS |volume=26 |issue=13 |pages=945–50 |date=November 2015 |pmid=25505037 |doi=10.1177/0956462414563624 |url=}}</ref>.
:* Clinical studies show [[human immunodeficiency virus]] ([[HIV]]) also increases the risk of [[vaginal cancer]]<ref name="pmid25505037">{{cite journal |vauthors=Davies O, Rajamanoharan S, Balachandran T |title=Cervical screening in HIV-positive women in the East of England: recent CD4 as the predictive risk factor |journal=Int J STD AIDS |volume=26 |issue=13 |pages=945–50 |date=November 2015 |pmid=25505037 |doi=10.1177/0956462414563624 |url=}}</ref>.
*'''Unhealthy lifestyle: '''
*'''Unhealthy lifestyle: '''


:* Epidemiological research demonstrates smoking and alcohol increase the risk of vaginal cancer<ref name="pmid22366589">{{cite journal |vauthors=Santoso JT, Crigger M, English E, Wan J, Likes W |title=Smoking cessation counseling in women with genital intraepithelial neoplasia |journal=Gynecol. Oncol. |volume=125 |issue=3 |pages=716–9 |date=June 2012 |pmid=22366589 |doi=10.1016/j.ygyno.2012.02.018 |url=}}</ref>.
:* Epidemiological research demonstrates [[smoking]] and [[alcohol]] increase the risk of [[vaginal cancer]]<ref name="pmid22366589">{{cite journal |vauthors=Santoso JT, Crigger M, English E, Wan J, Likes W |title=Smoking cessation counseling in women with genital intraepithelial neoplasia |journal=Gynecol. Oncol. |volume=125 |issue=3 |pages=716–9 |date=June 2012 |pmid=22366589 |doi=10.1016/j.ygyno.2012.02.018 |url=}}</ref>.
*'''Age: '''
*'''Age: '''


:* Approximately 85 percent of the cases of vaginal cancer occur in women who are over the age of 40, and nearly 50 percent of cases occur in women age 70 or older<ref name="pmid24423603">{{cite journal |vauthors=Strander B, Hällgren J, Sparén P |title=Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality |journal=BMJ |volume=348 |issue= |pages=f7361 |date=January 2014 |pmid=24423603 |pmc=3898577 |doi=10.1136/bmj.f7361 |url=}}</ref>.
:* Approximately 85 percent of the cases of [[vaginal cancer]] occur in women who are over the age of 40, and nearly 50 percent of cases occur in women age 70 or older<ref name="pmid24423603">{{cite journal |vauthors=Strander B, Hällgren J, Sparén P |title=Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality |journal=BMJ |volume=348 |issue= |pages=f7361 |date=January 2014 |pmid=24423603 |pmc=3898577 |doi=10.1136/bmj.f7361 |url=}}</ref>.


==References==
==References==

Latest revision as of 12:29, 6 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Syed Musadiq Ali M.B.B.S.[2]

Vaginal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Vaginal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Staging

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Vaginal cancer risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Vaginal cancer risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Vaginal cancer risk factors

CDC on Vaginal cancer risk factors

Vaginal cancer risk factors in the news

Blogs on Vaginal cancer risk factors

Directions to Hospitals Treating Vaginal cancer

Risk calculators and risk factors for Vaginal cancer risk factors

Overview

The risk factors of vaginal cancer may include vaginal adenosis, cervical cancer, diethylstilbestrol, human papillomavirus infection, HIV infection, unhealthy lifestyle, and age.

Risk factors

Clinical data has suggested that the development of vaginal cancer is related to several factors.

  • Clinical research suggest that having adenosis increases the risk of developing clear cell carcinoma. Although it is very small, many doctors feel that any woman with adenosis should have very careful screening and follow-up[1].
  • HIV infection:
  • Unhealthy lifestyle:
  • Age:
  • Approximately 85 percent of the cases of vaginal cancer occur in women who are over the age of 40, and nearly 50 percent of cases occur in women age 70 or older[7].

References

  1. Vessey MP (1989). "Epidemiological studies of the effects of diethylstilboestrol". IARC Sci. Publ. (96): 335–48. PMID 2680951.
  2. Jain G, Sabeena S, Vasudeva A, Mundkur A, Srinivas SP, Arunkumar G, Kumar P (December 2018). "A report of human papilloma virus-16 associated vaginal carcinoma after thirty-two years of successful radiation therapy for cervical cancer". Virusdisease. 29 (4): 537–539. doi:10.1007/s13337-018-0479-8. PMID 30539058.
  3. Huo D, Anderson D, Palmer JR, Herbst AL (September 2017). "Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up". Gynecol. Oncol. 146 (3): 566–571. doi:10.1016/j.ygyno.2017.06.028. PMID 28689666.
  4. Pham T, Bi X, Hoang H, Ishizaki A, Nguyen M, Nguyen CH, Nguyen HP, Pham TV, Ichimura H (November 2018). "Human Papillomavirus Genotypes and HPV16 E6/E7 Variants among Patients with Genital Cancers in Vietnam". Jpn. J. Infect. Dis. 71 (6): 419–426. doi:10.7883/yoken.JJID.2018.206. PMID 29962490. Vancouver style error: initials (help)
  5. Davies O, Rajamanoharan S, Balachandran T (November 2015). "Cervical screening in HIV-positive women in the East of England: recent CD4 as the predictive risk factor". Int J STD AIDS. 26 (13): 945–50. doi:10.1177/0956462414563624. PMID 25505037.
  6. Santoso JT, Crigger M, English E, Wan J, Likes W (June 2012). "Smoking cessation counseling in women with genital intraepithelial neoplasia". Gynecol. Oncol. 125 (3): 716–9. doi:10.1016/j.ygyno.2012.02.018. PMID 22366589.
  7. Strander B, Hällgren J, Sparén P (January 2014). "Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality". BMJ. 348: f7361. doi:10.1136/bmj.f7361. PMC 3898577. PMID 24423603.